Joan K Orrell-Valente1, Leah G Jarlsberg, Laura G Hill, Michael D Cabana. 1. Department of Pediatrics, Philip Lee Institute of Health Policy Studies, University of California, Division of Adolescent Medicine, 3333 California St, LH 245, Box 0503, San Francisco, CA 94143-0503, USA. joan.valente@ucsf.edu
Abstract
OBJECTIVE: Use of daily controller medications is a critical task in management of persistent asthma. Study aims were to examine (1) the association between child age and extent of daily controller-medication responsibility in a sample aged 4 to 19 years, (2) parent, child, and disease predictors of child daily controller-medication responsibility and overall daily controller-medication adherence, and (3) the association between child daily controller-medication responsibility and overall daily controller-medication adherence. METHODS: We conducted a cross-sectional telephone survey of 351 parents of children who were prescribed daily controller medication. Children's mean age was 10.4 years; 61.5% were male, and 88.1% were white. Parents provided all data, including an estimate of the percentage of child and parent daily controller-medication responsibility. Daily controller-medication adherence was measured as parents' report of percentage of daily doses taken per doses prescribed in a typical week. We used multivariate linear regression to determine associations between parent race/ethnicity, education, income, number of dependents, child age, gender, years since diagnosis, parent perception of symptom severity and control, and dependent variables (child daily controller-medication responsibility and daily controller-medication adherence). We also examined associations between child daily controller-medication responsibility and daily controller-medication adherence. RESULTS: Child daily controller-medication responsibility increased with age. By age 7, children had assumed, on average, almost 20% of daily controller-medication responsibility; by age 11, approximately 50%; by age 15, 75%; and by age 19, 100%. In multivariate models, child age and male gender remained significantly associated with child daily controller-medication responsibility, and child's age and parents' race/ethnicity remained significantly associated with daily controller-medication adherence. CONCLUSIONS: Clinicians may need to screen for child daily controller-medication management and include even young children when educating families on the use of asthma medications and other key asthma-management tasks.
OBJECTIVE: Use of daily controller medications is a critical task in management of persistent asthma. Study aims were to examine (1) the association between child age and extent of daily controller-medication responsibility in a sample aged 4 to 19 years, (2) parent, child, and disease predictors of child daily controller-medication responsibility and overall daily controller-medication adherence, and (3) the association between child daily controller-medication responsibility and overall daily controller-medication adherence. METHODS: We conducted a cross-sectional telephone survey of 351 parents of children who were prescribed daily controller medication. Children's mean age was 10.4 years; 61.5% were male, and 88.1% were white. Parents provided all data, including an estimate of the percentage of child and parent daily controller-medication responsibility. Daily controller-medication adherence was measured as parents' report of percentage of daily doses taken per doses prescribed in a typical week. We used multivariate linear regression to determine associations between parent race/ethnicity, education, income, number of dependents, child age, gender, years since diagnosis, parent perception of symptom severity and control, and dependent variables (child daily controller-medication responsibility and daily controller-medication adherence). We also examined associations between child daily controller-medication responsibility and daily controller-medication adherence. RESULTS:Child daily controller-medication responsibility increased with age. By age 7, children had assumed, on average, almost 20% of daily controller-medication responsibility; by age 11, approximately 50%; by age 15, 75%; and by age 19, 100%. In multivariate models, child age and male gender remained significantly associated with child daily controller-medication responsibility, and child's age and parents' race/ethnicity remained significantly associated with daily controller-medication adherence. CONCLUSIONS: Clinicians may need to screen for child daily controller-medication management and include even young children when educating families on the use of asthma medications and other key asthma-management tasks.
Authors: Jean-Marie Bruzzese; Cesalie Stepney; Elizabeth K Fiorino; Lea Bornstein; Jing Wang; Eva Petkova; David Evans Journal: J Asthma Date: 2011-12-07 Impact factor: 2.515
Authors: Michelle Boyd; Toby J Lasserson; Michael C McKean; Peter G Gibson; Francine M Ducharme; Michelle Haby Journal: Cochrane Database Syst Rev Date: 2009-04-15
Authors: Priya S Prashad; Carole L Marcus; Jill Maggs; Nicolas Stettler; Mary A Cornaglia; Priscilla Costa; Kristina Puzino; Melissa Xanthopoulos; Ruth Bradford; Frances K Barg Journal: J Clin Sleep Med Date: 2013-12-15 Impact factor: 4.062
Authors: Sean M Frey; Marybeth R Jones; Nicolas Goldstein; Kristin Riekert; Maria Fagnano; Jill S Halterman Journal: Acad Pediatr Date: 2018-01-31 Impact factor: 3.107
Authors: Giselle Mosnaim; Hong Li; Molly Martin; Dejuran Richardson; Paula Jo Belice; Elizabeth Avery; Norman Ryan; Bruce Bender; Lynda Powell Journal: Ann Allergy Asthma Immunol Date: 2013-12-21 Impact factor: 6.347